Author

M. Giurg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

M. Burda-Grabowska· 2 shared D. Nayak· 1 shared E. Weglarz-Tomczak· 1 shared J. Granda· 1 shared J. M. Tomczak· 1 shared K. Olech· 1 shared L. Zhang· 1 shared M. Drag· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

M. Burda-Grabowska

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases - PLpro and Mpro in in vitro studies

M. Zmudzinski, W. Rut, K. Olech, J. Granda, M. Giurg, M. Burda-Grabowska, L. Zhang, X. Sun, Z. Lv, D. Nayak, M. Kesik-Brodacka, S. Olsen, R. Hilgenfeld, M. Drag

This study identifies ebselen derivatives as potent inhibitors of SARS-CoV-2 proteases PLpro and Mpro in vitro, with some compounds showing greater potency than ebselen itself.

bioRxiv · Aug 30, 2020 · PreprintBiochemistry

Discovery of potent inhibitors of PLproCoV2 by screening libraries of selenium-containing compounds

E. Weglarz-Tomczak, J. M. Tomczak, M. Giurg, M. Burda-Grabowska, S. Brul

The paper screens selenium-containing compounds to identify potent inhibitors of SARS-CoV-2 PLpro, finding four nanomolar-range inhibitors.

bioRxiv · May 20, 2020 · PreprintBiochemistry